Suicide gene stem cells target deadly brain tumor after surgery
NCT ID NCT07143812
Summary
This early-stage trial is testing a new type of stem cell treatment for people with a newly diagnosed, aggressive brain cancer called glioblastoma. The stem cells are modified to carry a 'suicide gene' and are injected directly into the brain after surgery. The main goal is to see if this approach is safe and to find the right dose, with the hope that it can target leftover cancer cells and delay the tumor's return.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA (GBM) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Bundang CHA Medical Center
RECRUITINGSeongnam, Kyunggido, 13496, South Korea
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.